Evidence map›Paper›PMID 40302273›Full record

ArticleInternational journal of qualitative studies on health and well-being2025

Triggers of treatment interruption and resumption among individuals with type 2 diabetes: a narrative cross-sectional qualitative study.

Tomoo Hidaka, Rieko Suzuki, Katsue Hashimoto, Mariko Inoue, Shota Endo, Takeyasu Kakamu, Mariko Gunji, Koichi Abe, Tetsuhito Fukushima

Abstract read
In one paragraph

Article in International journal of qualitative studies on health and well-being, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tomoo HidakaDepartment of Hygiene and Preventive Medicine, Fukushima Medical University, Fukushima, Japan.ORCID 0000-0003-2987-4804
Rieko SuzukiHealth Promotion Division, Koriyama City Public Health Center, Fukushima, Japan.
Katsue HashimotoHealth Promotion Division, Koriyama City Public Health Center, Fukushima, Japan.
Mariko InoueCMRQ Development Division, Novo Nordisk Pharma Ltd., Tokyo, Japan.
Shota EndoDepartment of Hygiene and Preventive Medicine, Fukushima Medical University, Fukushima, Japan.ORCID 0000-0002-7459-6092
Takeyasu KakamuDepartment of Hygiene and Preventive Medicine, Fukushima Medical University, Fukushima, Japan.ORCID 0000-0001-6920-8457
Mariko GunjiDirector, Koriyama City Public Health Center, Fukushima, Japan.
Koichi AbeDepartment of Orthopedic Surgery, Igarashi Clinic of Medicine and Surgery, Fukushima, Japan.
Tetsuhito FukushimaDepartment of Hygiene and Preventive Medicine, Fukushima Medical University, Fukushima, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTreatment interruption and resumption are common among people with type 2 diabetes mellitus (T2D), but the triggers of resumption, according to the reasons for interruption, remain underexplored. This study examined patterns of treatment interruption and resumption.

methodsNarratives from 13 T2D patients with a history of treatment interruption were analysed through semi-structured interviews.

resultsFour patterns were identified: 1) "Economic rationality", where financial barriers caused interruptions, but resumption was facilitated by low-cost check-ups and updated patient mindsets to manage medical expenses within the constraints of a limited household budget; 2) "Proactive information seeking", where doubts about treatment effectiveness led to interruptions, followed by resumption through active health risk reassessment by the patient's self-directed efforts; 3) "Health professional-patient relationship", where conflicts with healthcare providers prompted interruptions, but trustful encounters encouraged resumption; and 4) "Sustained partnerships with community health professionals", where personal challenges caused interruptions, but non-coercive partnerships with community health professionals fostered resumption through strengthened patient commitment.

conclusionThis study highlights the need for tailored medical support and local policy development for T2D patients, emphasizing subjective interpretations of their experiences on treatment interruption and resumption. Recognizing these patterns can guide resource allocation and the design of community-based diabetes care interventions.

Indexed as

Diabetes Mellitus, Type 2AdultAgedCross-Sectional StudiesFemaleHumansMaleMiddle AgedNarrationProfessional-Patient RelationsQualitative ResearchTreatment Interruptioncommitmentpatient dropoutspublic health nursesecondary preventionthematic analysisTreatment cessation

Identifiers

PMID40302273
PMCPMC12044906

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.